A child with acute lymphoblastic leukemia complicated by pericardial effusion. 1986

T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D010490 Pericardial Effusion Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE. Chylopericardium,Hemopericardium,Chylopericardiums,Effusion, Pericardial,Effusions, Pericardial,Pericardial Effusions
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
April 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
April 2023, Annals of medicine and surgery (2012),
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
May 2005, Journal of pediatric hematology/oncology,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
April 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
June 1976, Pediatrics,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
February 1990, British heart journal,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
May 2005, Heart and vessels,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
October 2015, Pediatric emergency care,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
April 2000, Medical and pediatric oncology,
T Horikoshi, and Y Hiyoshi, and M Ota, and K Kimura, and S Dai, and Y Ito, and H Kato
December 2023, Medicine,
Copied contents to your clipboard!